同德化工(002360.SZ)擬出資4700萬元與君門凱旋共設平潭同芯
格隆匯 1 月 11日丨同德化工(002360.SZ)公佈,根據公司未來的發展規劃,為促進公司多元快速發展和業績的持續、穩定增長,提升公司的盈利能力和競爭力,公司擬出資4700萬元與君門凱旋(北京)科貿有限公司(“君門凱旋”)共同投資設立平潭同芯投資合夥企業(有限合夥)(暫定名,具體名稱以工商登記為準,“平潭同芯”)。其中,4500萬元投資於平潭匯芯投資合夥企業(有限合夥)(暫定名,具體名稱以工商登記為準),平潭匯芯投資合夥企業(有限合夥)的投資領域為半導體行業。平潭同芯擬定註冊資本為4710萬元人民幣,其中君門凱旋為普通合夥人(GP),認繳出資額10萬元,公司為有限合夥人(LP),認繳出資額4700萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.